DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Buys $249,994.42 in Stock

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

DENTSPLY SIRONA Trading Up 0.7 %

Shares of NASDAQ:XRAY traded up $0.11 during mid-day trading on Thursday, reaching $16.26. 2,609,787 shares of the company's stock were exchanged, compared to its average volume of 2,605,293. The firm has a market capitalization of $3.23 billion, a price-to-earnings ratio of -7.86, a PEG ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a twelve month low of $15.47 and a twelve month high of $34.28. The business's fifty day moving average price is $18.65 and its 200-day moving average price is $21.28.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 3.94%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -14.07%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of a number of research reports. Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research note on Tuesday, December 3rd. Morgan Stanley decreased their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research note on Tuesday, December 17th. Mizuho initiated coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They set a "neutral" rating and a $21.00 target price on the stock. Finally, Needham & Company LLC decreased their target price on shares of DENTSPLY SIRONA from $25.00 to $23.00 and set a "buy" rating on the stock in a research note on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and an average target price of $23.58.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after acquiring an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC boosted its position in DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after acquiring an additional 348,532 shares during the last quarter. Nuance Investments LLC boosted its position in DENTSPLY SIRONA by 25.0% during the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in DENTSPLY SIRONA by 18.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after acquiring an additional 1,975,404 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its position in DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after acquiring an additional 314,343 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.